She seems to contradict herself and other documentary evidence, too. She is a key witness, and I don't find her very credible.
Agreed, Pinchasi is too facile with her words. (#603) It may help navigate Scilla (PTO) and Charybdis (FDA) but the judge will notice.
Sandoz response on Findings of Fact also presents an interesting view of the way the safe harbor is used: to duplicate Copaxone; and then we see a real life patent-work-around of the time-temperature reaction limiting step which is replaced with the use of an embedded viscosity measurement to limit the reaction.
ij
It is astonishing what foolish things one can temporarily believe if one thinks too long alone ... where it is often impossible to bring one's ideas to a conclusive test either formal or experimental. J.M. Keynes
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.